Mereo BioPharma (MREO) Shares Issued (2021 - 2026)

Mereo BioPharma (MREO) has reported Shares Issued for 6 consecutive years, with $19.9 million the latest figure, recorded in Q1 2026.

• Quarterly Shares Issued rose 46.21% year-over-year to $19.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.9 million (up 46.21% YoY) and the FY2025 annual result came in at $13.5 million, up 19.58% from the prior year.
• Shares Issued grew to $19.9 million in Q1 2026 per MREO's latest filing, from $13.5 million in the prior quarter.
• Over the last five years, Shares Issued for MREO reached as high as $19.9 million in Q1 2026 and fell as low as $8.0 million in Q4 2022.
• A 5-year average of $12.5 million and a median of $11.9 million in 2024 frame the typical range for Shares Issued.
• Annual changes were most pronounced in 2022 — Shares Issued jumped 51.31% — and 2025, when it gained 14.79%.
• Year by year, Shares Issued stood at $8.0 million in 2022, then rose by 19.29% to $9.6 million in 2023, then increased by 17.47% to $11.3 million in 2024, then gained by 19.58% to $13.5 million in 2025, then jumped by 47.56% to $19.9 million in 2026.
• According to Business Quant data, Shares Issued over the past three periods registered $19.9 million, $13.5 million, and $13.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.